Early Access — free while we kick the tires
EdgarHawk

Clowes Howard

Director

Director
1 filing analyzed · 1 company · Latest 2024-09-13

Companies

Company Buys Sells Direction
PLUS THERAPEUTICS, INC. PSTV 1 0 Net buying

Activity

September 2024
high
Buy
5,000 shares
$6,681
Significance 8/10

Director Clowes Howard bought 5,000 PSTV shares at $1.34 on 2024-09-11; 4 other insiders also bought within 14 days amid unprofitable operations.

Clowes Howard, a Director, purchased 5,000 shares at $1.34, expanding his holdings to 26,497 shares—a 23.3% increase. This transaction occurs as part of a cluster pattern: 4 other insiders also bought PSTV stock within the past 14 days, suggesting coordinated or synchronized confidence in the stock despite material headwinds. The company is currently unprofitable with a net income of $-2.9M in its latest quarter, though it posted annual revenue growth of +36.5% year-over-year. Notably, Howard's prior 4 purchases at PSTV all demonstrated positive 90-day returns (ranging from +1,616.8% to +3,633.2%), and his cross-ticker track record across 4 prior buys shows an average 90-day return of +2,192.4% with a 100% win rate. The convergence of multiple insider purchases amid unprofitable fundamentals but strong revenue trajectory and Howard's consistent timing success at this ticker warrants investor attention to the company's operational turnaround narrative.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access